Pay in 4 interest-free payments of $6.21 Learn more
Ships within 48 hours · Estimated delivery Aug 20 - Aug 25
Ten drugs were subject to MFPs beginning in 2026, including Eliquis (apixaban, Bristol-Myers Squibb/Pfizer), Jardiance (empagliflozin, Boehringer Ingelheim/Eli Lilly), Xarelto (rivaroxaban, Johnson & Johnson/Bayer), and Januvia (sitagliptin, Merck)
If and when retatrutide receives marketing authorisation from bodies such as the Medicines and Healthcare products Regulatory Agency (MHRA) or the European Medicines Agency (EMA) a formal Summary of Product Characteristics (SmPC) will define the recommended dosing regimen
October 13, 2025
These food-based GLP-1 strategies may support microbial fermentation, satiety signaling, and metabolic balance as part of a broader diet-first approach
US$ 22.64
US$ 27.78
US$ 20.18
US$ 26.86
US$ 23.70
US$ 24.29
US$ 27.42
US$ 24.06
US$ 26.04
US$ 25.61
US$ 24.80
US$ 28.33
US$ 20.93
US$ 23.87
US$ 21.29
US$ 24.37
